GlaxoSmithKline is to acquire the Pakistan unit of Bristol-Myers Squibb for £25m, including a portfolio of 30 pharmaceutical brands. [23-Dec-2008]
Intercytex has acquired Axordia, the Sheffield-based stem cell therapies firm, for £1.7m. [23-Dec-2008]
I-Path Diagnostics has secured a £1m venture capital investment to fund the expansion of its Belfast-based biomedical technologies business. [19-Dec-2008]
Crown Paints is to shed 140 of the 1,500 jobs at its paint manufacturing operations in Darwen, Hull, Warrington, Belfast and Dublin. [19-Dec-2008]
GE Healthcare is to stop production of radiochemicals at its site in Cardiff over the next 18 months, with the loss of up to 155 of the 420 jobs, but 150 biotechnology research jobs will be created. [18-Dec-2008]
Dow Chemical is to permanently close its emulsion polymers plant in King's Lynn with the loss of 30 jobs, but the 75-acre site will continue to produce insulation and insecticides. [17-Dec-2008]
Pharmaceutical Profiles, the Nottingham-based drug development company with 75 staff, has been acquired by Quotient Bioscience Group of Newmarket for undisclosed terms. [17-Dec-2008]
DCS Manufacturing is to relocate its health and beauty products factory from Wolverhampton to a 60,000 sq ft unit at Stratford-on-Avon by February 2009. [17-Dec-2008]
Essentially Scottish Botanicals is to create 22 jobs in a £2.3m investment in essential oils production at the former Lovat Water bottling plant in Fanellan, Inverness. [15-Dec-2008]
Baxter Healthcare is to set up a new £3.5m 38,000 sq ft drug manufacturing and research facility at the Liverpool Innovation Park on Merseyside by 2010. [09-Dec-2008]
Plethora Solutions has raised almost £1m from a share placing and advanced payment to fund the development of treatments for urological disorders. [09-Dec-2008]
Newcastle University has won £20m of funding from the Engineering & Physical Sciences Research Council to set up a centre for Biopharmaceutical Process Development. [08-Dec-2008]
Thornton & Ross is to acquire the muscle pain treatment brand Radian B from William Ransom & Son for £3.4m. [08-Dec-2008]
Yule Catto has sold PFW, the Dutch manufacturer of aroma chemicals, to Keva UK for £5.8m. [05-Dec-2008]
Sevalco is to close its carbon black chemicals factory in Avonmouth, with the loss of 88 jobs. [04-Dec-2008]
GlaxoSmithKline is to shed 200 jobs at its pharmaceuticals factory at Barnard Castle in County Durham over the next 18 months. [03-Dec-2008]
INEOS Compounds is to shed 13 jobs at its PVC compounds factory in Helsby, Cheshire, early next year, in order to transfer some of the production to a new site in Newton Aycliffe. [02-Dec-2008]
Dermasalve, the Tyneside-based developer of medicated skincare products, has gone into insolvency through David Rubin & Partners. [27-Nov-2008]
One NorthEast is expected to part-fund a £40m project proposed by the Middlesbrough-based National Skills Academy for the Process Industries to set up a chemical industry training centre over the next three years. [25-Nov-2008]
GlaxoSmithKline is to acquire AZ Tika, the Swedish supplier of over-the-counter medicines, from AstraZeneca for £146m. [24-Nov-2008]
Henkel UK is to close its adhesives plant in Newark next year, with the loss of up to 35 jobs, in order to transfer production to Germany and Italy. [24-Nov-2008]
AstraZeneca is to shed 1,400 jobs from its pharmaceuticals business by 2013, affecting sites in Macclesfield, Spain, Sweden and Belgium. [21-Nov-2008]
Yule Catto is to shed up to 15 of the 180 jobs at its Synthomer latex and emulsion polymers plant in Stallingborough early next year. [21-Nov-2008]
United Drug has acquired The Specials Laboratory, the Northumberland-based manufacturer of unlicensed medicines with 120 staff, for £20m. [20-Nov-2008]
Cambridge University has secured a £82m donation from the Gatsby Foundation to set up the Sainsbury Laboratory to study plant development by 2010, employing 120 scientists and 30 other staff. [19-Nov-2008]
Source BioScience of Nottingham is planning to set up a DNA and genetics testing research laboratory at University College London. [19-Nov-2008]
Pfizer is to set up a £41m stem cell research centre at Granta science park in Cambridge, employing about 40 researchers. [17-Nov-2008]
Hydrochem is planning to double the size of its 10,000 sq ft water treatment chemicals factory in Hartlepool by early next year, and expects to increase the 14-strong workforce with ten new jobs over the next three years. [12-Nov-2008]
ITI Life Sciences, the Dundee-based innovation body set up by Scottish Enterprise, is to invest £9.3m in research into the next generation of drug discovery targets over the next four years. [12-Nov-2008]
GlaxoSmithKline is to close its pharmaceuticals manufacturing plant at Dartford in Kent by 2013, with the loss of 620 jobs. [12-Nov-2008]
Big DNA has secured £1.5m to fund the expansion of its Roslin-based life sciences business, including the development of new vaccine technology. [04-Nov-2008]
GlaxoSmithKline is to acquire Genelabs Technologies, the US biopharmaceuticals company, for £35m. [31-Oct-2008]
Budelpack COSi is to shed a further 81 of the 417 jobs at its cosmetics and toiletries factory in Maesteg. [30-Oct-2008]
York Pharma has bought the assets of Celltran, the Sheffield-based biotechnology company with two wound care products, out of administration. [29-Oct-2008]
Shasun Pharma Solutions of India is to close its pharmaceuticals plant at Annan in Dumfriesshire next March, with the loss of 86 jobs. [28-Oct-2008]
Aquapharm is looking to raise a further £4m to fund the expansion of its Scottish biotechnology business, and hopes to agree a commercial licensing deal to develop anti-dandruff shampoos from marine microbes. [28-Oct-2008]
L'Oreal is to shed 200 of the 260 jobs at its shampoos factory at Llantrisant in South Wales, in order to transfer production to France. [27-Oct-2008]
Catch is looking to invest £7m in the expansion of its chemical industry training facility at Stallingborough, including new workshops, a mock process plant and an enlarged conference area. [22-Oct-2008]
Apitope, the Bristol-based biotechnology company, is to transfer its headquarters to Belgium, having secured a £7.7m funding package from a group of investors in Belgium and Luxembourg. [22-Oct-2008]
GlaxoSmithKline is to acquire Biotene, the dry-mouth treatment, from Laclede of the US for £100m, in order to expand its consumer healthcare business. [22-Oct-2008]
Nobel Enterprises is to close its nitrocellulose chemicals plant at Ardeer in Ayrshire with the loss of up to 90 jobs. [21-Oct-2008]
Alliance Boots has acquired a 90% stake in Megapharm, the German oncology products supplier with 100 staff, for undisclosed terms. [20-Oct-2008]
Sert UK has acquired M&S Toiletries, the Wakefield-based supplier of health and beauty products with 140 staff, from the Scottish & Midland Co-operative Society for undisclosed terms. [17-Oct-2008]
GlaxoSmithKline has acquired the Egyptian off-patent drugs business of Bristol-Myers Squibb for £120m, including a manufacturing plant and 20 branded products. [16-Oct-2008]
Cancer Research UK and the Engineering & Physical Sciences Research Council are to invest £50m in the development of cancer imaging research projects in Newcastle, Birmingham, Guildford, Sheffield and St Andrews over the next five years. [08-Oct-2008]
Norfolk County Council is to consider proposals from the Biotechnology & Biological Sciences Research Council to set up a £13m life sciences research centre at Norwich Research Park. [08-Oct-2008]
Bodycare Toiletries of Preston has been sold out of administration to a former management team for undisclosed terms, securing the future of 147 jobs. [08-Oct-2008]
Ineos is considering plans to close its G4 ethylene plant in Grangemouth next year, but £86m is being invested in the site's KG ethylene plant. [03-Oct-2008]
GlaxoSmithKline is said to be considering plans to relocate about 800 staff from Greenford to its Stockley Park site in Uxbridge next year. [02-Oct-2008]
BWA Water Additives, the Stretford-based water additives supplier, is to be acquired by Bahrain-based United International Bank for £100m. [01-Oct-2008]
GlaxoSmithKline has announced plans to shed a further 850 research and development jobs in the UK and the US. [01-Oct-2008]
Akzo Nobel is to shed 3,500 jobs in its global paints and chemicals business by 2011, including some of the 4,500 UK jobs at plants in Leicester, Slough, Tyne & Wear and Worcestershire. [30-Sep-2008]
BASF Construction Chemicals is to stop producing mortars at its Swinton site, with the loss of up to 45 production and marketing jobs. [29-Sep-2008]
Medifiq is to close its healthcare products factory at Rainton Bridge on Wearside with the loss of 90 jobs. [25-Sep-2008]
Alba Bioscience has secured a £1.8m grant from Scottish Enterprise that will create up to 16 research jobs at its Edinburgh-based life sciences business. [24-Sep-2008]
Controlled Therapeutics has secured a £1m Scottish Government grant that will lead to the creation of 23 new jobs at its life sciences research business in East Kilbride. [24-Sep-2008]
CaridianBCT is to invest £16m in the expansion of its blood collection and processing devices business in County Antrim, with the creation of 235 jobs over the next three years. [19-Sep-2008]
Protherics, the biotechnology company with 300 staff at sites in Runcorn, London, Ceredigion, Australia and the US, is to be acquired by BTG for £218m. [19-Sep-2008]
Cyclacel is to shed 17 jobs at its biotechnology research operation in Dundee, and its Cambridge site will close with the loss of seven jobs. [19-Sep-2008]
GlaxoSmithKline is to shed up to 20 of the 1,100 jobs at its pharmaceuticals plant in Barnard Castle, County Durham. [19-Sep-2008]
Ineos Chlor has won government permission to build a £330m waste-fuelled power station at its chemicals plant in Runcorn. [17-Sep-2008]
The Health Protection Agency is expected to announce plans for a multi-million pound investment in the rebuilding of the Porton Down disease research laboratories near Salisbury. [17-Sep-2008]
Syntropharma has raised £1.2m from investors to fund clinical trials for its Borders-based pharmaceuticals business. [12-Sep-2008]
Cellzome, the biotechnology company with 95 staff in Cambridge and Germany, has agreed a deal worth up to £800m with GlaxoSmithKline to develop pharmaceuticals for inflammatory diseases. [11-Sep-2008]
Intercytex of Manchester has raised £2.7m in a share placing to fund the commercial development of regenerative medicines that restore skin and hair. [10-Sep-2008]
Rohm & Haas is to shed 24 jobs at its chemicals plant in Jarrow, following a fall in demand for paints and preservatives. [10-Sep-2008]
Bespak is seeking permission from West Norfolk Council to build a new £1m inhalers factory at its site in King's Lynn. [05-Sep-2008]
Warwick International, the North Wales-based chemicals manufacturer with 380 staff, has undergone a £129m management buy-out backed by Close Brothers Private Equity. [03-Sep-2008]
BHM Health Group, the Bridlington-based supplier of vitamins and supplements with 41 staff, has been sold out of administration by BDO Stoy Hayward to local firms B-Bio and Sharplook. [01-Sep-2008]
Oxford Biomedica is to shed about nine of the 90 jobs at its gene therapy business in Oxford. [01-Sep-2008]
Sareum Holdings has sold some of the assets of its Sareum drug discovery service subsidiary to Galapagos of the Netherlands for £0.6m, with the transfer of five staff to BioFocus DPI in Saffron Walden. [27-Aug-2008]
Ely Chemical Company is to close its paints factory in Ely by the end of the year with the loss of 30 jobs, and the work will be transferred to other Chemetall sites. [22-Aug-2008]
Akzo Nobel has sold Crown Paints, its paint manufacturing business with 1,500 staff at factories in Darwen and Hull, to a management buy-out backed by private equity firm Endless for £70m. [20-Aug-2008]
Energy Power Resources is seeking permission to build an 80,000 sq m shed to produce fertiliser from by-products at its chicken litter-fuelled power plant in Thetford. [19-Aug-2008]
ClinPhone, the Nottingham-based clinical trials technology company, is to be acquired by Parexel of the US for £91m. [18-Aug-2008]
Syngenta is to invest £75m in the expansion of its crop protection manufacturing facilities in Grangemouth and Huddersfield, while £35m will be spent at its Jealott's Hill research centre in Bracknell. [11-Aug-2008]
Clariant is considering plans to close its chemicals factory at Horsforth near Leeds with the loss of 160 jobs, but a further 80 jobs will be retained in sales and services. [01-Aug-2008]
GlaxoSmithKline is to shed 55 of the 300 jobs at its pharmaceuticals plant in Montrose. [30-Jul-2008]
Biocompatibles has acquired the business and net assets of BrachySciences, the US supplier of medical devices, for £11m. [28-Jul-2008]
Acambis, the vaccine manufacturer, is to be acquired by Sanofi-Aventis of France for £276m. [28-Jul-2008]
Yule Catto has sold its ultramarine pigment business to Rockwood Specialities Group for £36m, including Holliday Pigments, Holliday France and Holliday Chemical Espana. [22-Jul-2008]
Aesica is to shed 50 of the 160 jobs at its pharmaceuticals business in Northumberland, but still plans to treble sales to £150m over the next three years. [21-Jul-2008]
Ineos is planning to develop the first commercial-scale ethanol production plants fuelled by municipal waste by 2011, and will start agreeing deals over the next few months. [21-Jul-2008]
SABIC is to close two chemical production units on Teesside by the end of the year with the loss of up to 180 jobs, including the Aromatics 2 plant at Seal Sands and the Paraxylene plant at Wilton. [17-Jul-2008]
United Drug has acquired Sharp Corporation, the US-based pharmaceutical contract packaging firm with about 600 staff, for £50m. [17-Jul-2008]
Syntopix is to raise £1.5m in a share placing to fund the expansion of its Bradford-based drugs research and development business. [17-Jul-2008]
Immunodiagnostic Systems, the South Tyneside-based medical testing kit maker with 60 staff, is considering plans to open sales subsidiaries in Canada, Spain, Belgium and the Netherlands. [16-Jul-2008]
GlaxoSmithKline is to close its prescription medicines factory in Crawley in 2011, with the loss of up to 500 jobs. [14-Jul-2008]
ImmuPharma has raised £1.1m in a share placing to fund the expansion of its London-based drug discovery business. [11-Jul-2008]
Concateno, the drug and alcohol testing firm with a market value of £156m, has received a number of takeover approaches and has appointed UBS to explore its options. [09-Jul-2008]
PZ Cussons, the supplier of personal care products, is to relocate its headquarters from Stockport to a new 40,000 sq ft building at the Manchester Business Park in 2010. [08-Jul-2008]
York Pharma has acquired the worldwide commercial rights to the Flammazine and Flammacerium wound care products from Solvay Pharmaceuticals for £23m. [07-Jul-2008]
Shire is to acquire Jerini, the German biotechnology company, for £260m, in order to expand its genetic therapy business. [07-Jul-2008]
BWA Water Additives, the Stretford-based water additives supplier with an estimated value of £100m, has been put up for sale by its private equity owner Close Brothers. [02-Jul-2008]
Ardana, the Edinburgh-based biotechnology company, has gone into voluntary administration through Ernst & Young, having failed to find a buyer. [01-Jul-2008]
ALcontrol is to shed up to 70 of the 350 jobs at its soil testing laboratory at Hawarden in Flintshire. [27-Jun-2008]
GlaxoSmithKline is to shed 287 of the 480 jobs at its pharmaceuticals factory in Maidenhead over the next two years, in order to transfer production to eastern Europe. [26-Jun-2008]
The Medical Research Council has secured a £67m government grant to go towards the £197m rebuilding of the Laboratory of Molecular Biology in Cambridge. [25-Jun-2008]
Cyprotex, the Macclesfield-based drug discovery company, is to raise £1m in a share placing to fund the expansion of its commercial sales infrastructure and laboratories. [23-Jun-2008]
Procter & Gamble is said to be looking to relocate its Weybridge headquarters to a new site of up to 150,000 sq ft. [23-Jun-2008]
NeutraHealth has acquired Perrigo UK, the Derbyshire-based manufacturer of vitamin and mineral supplements, for £6.4m, and Perrigo will now trade under the Brunel Healthcare name. [18-Jun-2008]
Dow Chemical is to close the emulsion polymers production unit at its site in King's Lynn in September, with the loss of up to 20 of the 129 jobs. [16-Jun-2008]
First DataBank Europe is to relocate its Exeter-based pharmaceutical knowledge systems business and up to 63 staff to the Exeter Business Park this autumn. [12-Jun-2008]
GlaxoSmithKline is to shed about 350 research and development jobs in its global pharmaceuticals business, including some at Harlow in Essex. [12-Jun-2008]
Jeyes has acquired Power & Liquid Products, the County Durham-based supplier of cleaning products with annual sales of £15m, for undisclosed terms. [10-Jun-2008]
ICON, the provider of outsourced services to the pharmaceutical industry, is creating 60 jobs at its new operation in Edinburgh. [04-Jun-2008]
Stiefel, the pharmaceuticals group, is said to have agreed to set up a 49,000 sq ft headquarters at the Luminaire building in Maidenhead. [04-Jun-2008]
DxS Diagnostics, the personalised medicine specialist with 30 staff, is planning to double the size of its manufacturing facility in Manchester over the next few months. [29-May-2008]
Flexsys is to close its rubber chemicals factory at Cefn Mawr near Wrexham by the end of the year, with the loss of 163 jobs. [23-May-2008]
The Babraham Research Campus in Cambridgeshire has secured a £0.3m grant from the East of England Development Agency to fund a new biopharmaceutical development laboratory. [21-May-2008]
Hi-Tech Coatings, the Aylesbury-based supplier of coatings to the printing industry, has been acquired by Heidelberg of Germany for undisclosed terms. [20-May-2008]
Antisoma is to acquire Xanthus Pharmaceuticals, the US drug developer, for £27m. [19-May-2008]
Arizona Chemical is to close its chemicals plant at Bedlington in Northumberland in August with the loss of 43 jobs, and 31 jobs will also be lost at its site in Chester-le-Street, in order to transfer production to France and the US. [15-May-2008]
Intellego has acquired the assets of Zenosis, the publisher of compliance training courses for the pharmaceutical industry, out of administration. [13-May-2008]
The Scottish Police Services Authority is planning to set up a new multi-million pound forensic science laboratory in Dundee, and will now work with developers to acquire a suitable site. [12-May-2008]
Croda International has sold its Chicago Oleochemicals business in the US to private equity firm HIG Capital for £47m. [09-May-2008]
IS Pharma has raised finance of £8m to fund further acquisitions for its Chester-based pharmaceuticals business, which was previously known as Maelor. [05-May-2008]
Sciantec Analytical Services is to create 17 new jobs at its Cawood animal feeds and pharmaceuticals laboratory in Selby over the next six months, and some staff will relocate from its recently-acquired Central Laboratories division in Banbury. [05-May-2008]
Warwick International has acquired GME Chemicals, the Malaysian distributor of coatings, household chemicals and petrochemicals, for undisclosed terms. [01-May-2008]
Elementis is to acquire Deuchem, the Taiwan-based supplier of additives and resins, for £40m. [29-Apr-2008]
Ciba Specialty Chemicals is to close the research and technical centre at its pigments plant in Paisley, with the loss of 36 jobs from the site's 420-strong workforce. [29-Apr-2008]
Acambis is to raise £40m in a share placing to fund the expansion of its vaccine manufacturing and research business, which includes sites in Cambridge and the US. [24-Apr-2008]
GlaxoSmithKline is to acquire Sirtris Pharmaceuticals, the US drug discovery company, for £362m. [24-Apr-2008]
Lundbeck is to close its pharmaceuticals plant at Seal Sands near Redcar with the loss of 65 jobs, having failed to find a buyer for the business. [23-Apr-2008]
Vernalis has received a £15m cash injection from Paul Capital Healthcare, as part of a revenue-sharing deal for a migraine treatment. [22-Apr-2008]
Avon is to relocate the Northampton-based headquarters of its cosmetics business to Merchant Place's 100,000 sq ft office development on the River Nene next year. [22-Apr-2008]
Dundee University is to set up a new £10m life sciences institute called the Scottish Institute for Cell Signalling. [22-Apr-2008]
Deb, the manufacturer of Swarfega cleaning products, is to relocate up to 180 jobs from Belper to a new £20m headquarters in Denby in June 2009. [18-Apr-2008]
Lab901 has raised £3.5m from Alliance Trust Equity Partners and other investors to fund the expansion of its Edinburgh-based life sciences automation business. [17-Apr-2008]
Inverness Medical Innovations is considering plans to shed up to 20 of the 95 jobs at its diagnostic tests research centre in Stirling. [17-Apr-2008]
Hanworth Laboratories has acquired a 75% stake in Surefil Beauty Products, the St Helens-based cosmetics company with 100 staff, for £1.5m. [17-Apr-2008]
Shire, the pharmaceuticals group, is to relocate its tax base to Ireland, but the 300 staff will remain in Basingstoke. [16-Apr-2008]
Piramed, the Slough-based biotechnology company, is to be acquired by Roche of Switzerland for £90m. [15-Apr-2008]
CeNes, the Cambridge-based pharmaceuticals manufacturer with 15 staff, is to be acquired by Paion of Germany for £11m. [11-Apr-2008]
Auralis has secured a £1.4m capital investment from Aquarius Equity Partners to fund the expansion of its Cheshire-based pharmaceuticals business. [10-Apr-2008]
Myconostica of Manchester has raised £3.9m of venture capital to fund the commercial development of its biotechnology-based diagnostic products. [09-Apr-2008]
United Drug has acquired Universal Conference & Incentive Travel of Slough and Business Edge Solutions & Training of St Albans for a total £14m, in order to expand its contract sales division. [07-Apr-2008]
The British Heart Foundation is to set up a £7.6m research centre at the University of Edinburgh, as part of a £34m investment at sites including Imperial College London, King's College London and the University of Oxford. [07-Apr-2008]
GlaxoSmithKline is to shed 270 jobs at its pharmaceuticals plant in Irvine, Ayrshire, over the next three years. [03-Apr-2008]
Maelor has acquired Speciality European Pharma International, the Swiss pharmaceuticals company, for an initial £9.2m. [31-Mar-2008]
Akzo Nobel is looking to sell its Lancashire-based Crown Paints business for about £200m, having appointed Greenhill to find a buyer. [31-Mar-2008]
Phytopharm has raised £8.6m in a share placing to fund the commercial development of pharmaceuticals from medicinal plants. [26-Mar-2008]
Premier Research Group, the clinical research outsourcing company, is to undergo a £60m management buy-out backed by private equity firm ECI Partners. [25-Mar-2008]
Brotherton Speciality Products, the Wakefield-based chemicals company with about 50 staff, has been acquired by Esseco Group of Italy for undisclosed terms. [19-Mar-2008]
BASF has agreed to sell its acrylonitrile plant at Seal Sands on Teesside to Ineos Nitriles for undisclosed terms, with the transfer of 240 staff. [17-Mar-2008]
EUSA Pharma of Oxford has acquired Cytogen, the US biotechnology firm, for £11m, taking its worldwide workforce to more than 200. [13-Mar-2008]
Umeco has sold its chemical distribution businesses, including Aeropia and RD Taylor, to Haas TCM Group for £13m, in order to focus on advanced composites. [12-Mar-2008]
Perrigo is to shed about 129 of the 540 jobs at its pharmaceuticals factory in Braunton, North Devon, by the end of May. [10-Mar-2008]
Lundbeck is looking to sell or close its pharmaceuticals factory at Seal Sands on Teesside, with the possible loss of up to 65 jobs. [10-Mar-2008]
Alizyme has raised £10m in a share placing to fund the expansion of its Cambridge-based biopharmaceuticals business. [07-Mar-2008]
Current BioData, the supplier of scientific information services to the pharmaceuticals industry, is creating 45 jobs for biochemists and biologists at the Institute of Life Science at Swansea University. [07-Mar-2008]
AH Marks, the Bradford-based agricultural chemicals manufacturer with 300 staff, has been acquired by Nufarm of Australia, as part of a £75m deal that also included US-based Etigra. [06-Mar-2008]
Croda International has raised £13m from the sale of its 46% stake in Baxenden Chemicals, the Accrington-based supplier of polyurethane products, to Chemtura Corporation. [04-Mar-2008]
Antisoma, the biotechnology company, is to set up a 15,000 sq ft office at Chiswick Park in West London in May. [04-Mar-2008]
Novartis UK is to shed 30 of the 90 jobs at its Vericore animal pharmaceuticals factory in Dundee over the next two years. [28-Feb-2008]
D3 Technologies is to set up a research and development centre for clinical molecular diagnostic products at the Nova Business Park in Glasgow, with the creation of 22 jobs. [27-Feb-2008]
Illumina, the US biotechnology company, is to set up a new 41,500 sq ft European headquarters at Chesterford Research Park in Essex. [26-Feb-2008]
GlaxoSmithKline has confirmed plans to shed 330 of the 537 jobs at its pharmaceuticals factory in Ulverston, Cumbria, over the next two years. [25-Feb-2008]
Eastman Peboc is considering plans to close its fine chemicals plant on Anglesey with the loss of 65 jobs, unless a buyer can be found. [22-Feb-2008]
Atlas Genetics of Bath has secured £2.1m from the South West Ventures Fund and Braveheart Ventures to finance the development of its Velox System, which tests for lethal infections. [22-Feb-2008]
Vernalis is to shed 120 of the 210 jobs at its Wokingham-based biotechnology business, in order to focus on research and development. [21-Feb-2008]
Genzyme is planning to expand its pharmaceuticals factory in Haverhill, in order to increase production of the bulk polymer product for its kidney disease drug. [21-Feb-2008]
Medical Solutions is to acquire Autogen Bioclear UK, the Wiltshire-based supplier of life sciences, diagnostic pathology and clinical research products with nine staff, for up to £6m. [20-Feb-2008]
Avanticell Science has secured £1m of funding to develop new three-dimensional cell-based tests to assist in drug discovery, in partnership with Giltech of Ayr and Culzean Medical Devices of Prestwick. [20-Feb-2008]
Ardana is seeking a buyer for its Edinburgh-based pharmaceuticals business, in order to help fund its drug development programme. [20-Feb-2008]
Shasun Pharma Solutions is considering plans to build a new pharmaceuticals laboratory and expand the pilot project plant at its site in Cramlington over the next 18 months, with the creation of 55 jobs. [19-Feb-2008]
Stem Cell Sciences is planning to close its Edinburgh site and consolidate its pharmaceuticals research and senior management in Cambridge. [18-Feb-2008]
Teva UK is to set up a new 262,000 sq ft headquarters and pharmaceuticals distribution centre at the ProLogis site in Glasshoughton, Leeds, later this year. [15-Feb-2008]
Akzo Nobel is to shed 109 of the 650 jobs at its factory in Darwen, Lancashire, in order to transfer industrial paints production to Sweden at the end of the year. [14-Feb-2008]
Intertek has acquired Bioclin, the Irish pharmaceutical testing laboratory with 20 staff, for an initial £2.4m. [13-Feb-2008]
The Translational Medicine Research Collaboration (TMRC) is to provide £15m of funding to 39 medical research projects in Scotland, which could create up to 100 jobs at the universities of Aberdeen, Dundee, Edinburgh and Glasgow. [13-Feb-2008]
Hunter-Fleming, the Bristol-based biopharmaceuticals firm with 13 staff, has been acquired by Newron of Italy for up to £19m. [13-Feb-2008]
Yule Catto is to sell James Robinson, the Huddersfield-based manufacturer of photographic chemicals and hair dyes, to Vivimed Labs of India for £11m. [12-Feb-2008]
Perstorp is planning to double the capacity at its recently-acquired caprolactone chemicals factory in Warrington by 2010, which could increase the 65-strong workforce. [12-Feb-2008]
GrowHow UK is to invest £15m in the expansion of its ammonium nitrate plant in Billingham, securing the future of 200 jobs, and capacity will also increase at its plant near Chester. [08-Feb-2008]
AstraZeneca is planning to shed more than 300 jobs at the Alderley Park pharmaceuticals research centre near Wilmslow. [07-Feb-2008]
Siemens Healthcare Diagnostics is to expand its biotechnology products factory in Llanberis, Gwynedd, with the creation of up to 200 jobs over the next two years. [06-Feb-2008]
Whatman, the diagnostic products manufacturer with 1,100 staff in Maidstone, Banbury and throughout the world, is to be acquired by GE Healthcare for £363m. [05-Feb-2008]
NeutraHealth has acquired the Gerard House and Galloway herbal brands from Potters for £0.4m, in order to expand its Brunel Healthcare supplements division. [05-Feb-2008]
Drug Development Solutions, the Dundee-based pharmaceutical trials firm with 37 staff, has been acquired by Chiltern. [05-Feb-2008]
Ineos has won EC approval to acquire Kerling, the Norwegian PVC manufacturer with a site in Newton Aycliffe, for £500m. [01-Feb-2008]
PZ Cussons has acquired The Sanctuary Spa Holdings, the supplier of personal care products, for £75m. [30-Jan-2008]
UCB is to close its biopharmaceuticals research centre at Granta Park near Cambridge with the loss of 146 jobs, in order to transfer the work to sites in Slough and Belgium over the next six months. [25-Jan-2008]
Galpharm Healthcare, the Barnsley-based supplier of over-the-counter medicines with 64 staff, has been acquired by Perrigo Group of the US for £44m. [14-Jan-2008]
Quantum Specials is planning to expand the workforce at its County Durham-based pharmaceutical manufacturing business from 100 to 125 over the next year. [14-Jan-2008]
Novartis is considering plans to close its pharmaceuticals plant in Alfreton, with the loss of up to 130 jobs. [11-Jan-2008]
William Sinclair Holdings has acquired Joseph Metcalf, the Accrington-based horticultural chemicals supplier trading under the GEM brand, for £3m. [11-Jan-2008]
Hexcel has won approval from South Cambridgeshire District Council to build a carbon fibre chemical precursors plant in Duxford, and the application will now go to the Secretary of State. [11-Jan-2008]
Fusion Antibodies of Belfast has raised £1.2m to fund clinical trials for its new antibody drugs and to recruit four scientists. [10-Jan-2008]
Hale Group, the pharmaceuticals manufacturer with more than 100 staff in Widnes and Southport, is to be acquired by Marksans Pharma of India for undisclosed terms. [09-Jan-2008]
Ark Therapeutics is to acquire Lymphatix Oy of Finland for £1.7m, in order to gain access to new technology for the development of gene-based medicines. [09-Jan-2008]
Tor Coatings has bought the fire-retardant coatings business of Kent-based Bollom Fire Protection out of administration for undisclosed terms. [07-Jan-2008]